Rachel J. Roth Flach
Pfizer (United States)(US)
Publications by Year
Research Areas
Adipose Tissue and Metabolism, Diet and metabolism studies, Metabolomics and Mass Spectrometry Studies, Liver Disease Diagnosis and Treatment, Pancreatic function and diabetes
Most-Cited Works
- → IL-1 Signaling in Obesity-Induced Hepatic Lipogenesis and Steatosis(2014)164 cited
- → The Conserved Misshapen-Warts-Yorkie Pathway Acts in Enteroblasts to Regulate Intestinal Stem Cells in Drosophila(2014)138 cited
- → Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis(2015)120 cited
- → Hepatic Mitogen-Activated Protein Kinase Phosphatase 1 Selectively Regulates Glucose Metabolism and Energy Homeostasis(2014)86 cited
- → Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion(2016)60 cited
- → Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension(2020)56 cited
- → The Lipid Droplet Protein Hypoxia-inducible Gene 2 Promotes Hepatic Triglyceride Deposition by Inhibiting Lipolysis(2015)56 cited
- → Loss of Mitogen-activated Protein Kinase Phosphatase-1 Protects from Hepatic Steatosis by Repression of Cell Death-inducing DNA Fragmentation Factor A (DFFA)-like Effector C (CIDEC)/Fat-specific Protein 27(2011)54 cited
- → β3-Adrenergic Receptor Stimulation Induces E-Selectin-mediated Adipose Tissue Inflammation(2012)49 cited
- → MAP kinase phosphatase‐1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy(2010)48 cited